NCT07264426 Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study Status RECRUITING Phase N/A
NCT07091630 A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP Status RECRUITING Phase PHASE3
NCT06920004 A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP Status RECRUITING Phase PHASE3
NCT06714838 Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Status RECRUITING Phase PHASE3
NCT05723848 Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Status COMPLETED Phase N/A
NCT05614128 Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP Status TERMINATED Phase N/A
NCT04881682 Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Status RECRUITING Phase PHASE2
NCT04777734 Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Status AVAILABLE Phase N/A
NCT03801135 Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation Status UNKNOWN Phase NA
NCT02629796 Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Status COMPLETED Phase N/A
NCT01655394 Change of Nerve Conduction Properties in IVIg Dependent Neuropathies Status UNKNOWN Phase N/A
NCT00962429 Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy Status COMPLETED Phase PHASE2